2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.

Suppr

超能文献

作者信息

Robins R K, Srivastava P C, Narayanan V L, Plowman J, Paull K D

出版信息

J Med Chem. 1982 Feb;25(2):107-8. doi: 10.1021/jm00344a002.

DOI:10.1021/jm00344a002

PMID:7057413

Abstract

摘要

相似文献

2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.

J Med Chem. 1982 Feb;25(2):107-8. doi: 10.1021/jm00344a002.

Mechanism of resistance to the oncolytic C-nucleoside 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC-286193).

Biochem Pharmacol. 1982 Aug 1;31(15):2557-60. doi: 10.1016/0006-2952(82)90071-5.

Action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (tiazofurin) against untreated human ovarian cancers in the murine xenograft assay.

Gynecol Oncol. 1985 Jul;21(3):351-5. doi: 10.1016/0090-8258(85)90273-2.

Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinoma.

Invest New Drugs. 1988 Sep;6(3):217-8. doi: 10.1007/BF00175401.

Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193).

Biochem Pharmacol. 1982 Jul 15;31(14):2371-80. doi: 10.1016/0006-2952(82)90532-9.

Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193)--II. Relationship between dose level and biochemical effects in P388 leukemia in vivo.

Biochem Pharmacol. 1982 Dec 1;31(23):3839-45. doi: 10.1016/0006-2952(82)90300-8.

Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.与抗肿瘤剂2-β-D-呋喃核糖基噻唑-4-甲酰胺相关的核苷和核苷酸的合成及生物活性

J Med Chem. 1984 Mar;27(3):266-9. doi: 10.1021/jm00369a006.

Effect of 2-beta-D-ribofuranosylthiazole-4-carboxamide on uptake of nucleosides by cultured L1210 cells.

Cancer Lett. 1984 Aug;24(1):11-8. doi: 10.1016/0304-3835(84)90074-0.

Effectiveness of tiazofurin (NSC 286193) in treating disseminated tumor cells and micrometastases in mice.

Oncology. 1990;47(4):359-64. doi: 10.1159/000226848.

Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide--V. Factors governing the response of murine tumors to tiazofurin.2-β-D-呋喃核糖基噻唑-4-甲酰胺作用机制的研究——V. 影响小鼠肿瘤对替唑呋林反应的因素。

Biochem Pharmacol. 1984 Apr 15;33(8):1195-203. doi: 10.1016/0006-2952(84)90170-9.

引用本文的文献

Synthesis and Antitumor Activity of C-7-Alkynylated and Arylated Pyrrolotriazine C-Ribonucleosides.C-7-炔基化和芳基化吡咯并三嗪C-核糖核苷的合成及其抗肿瘤活性

ACS Med Chem Lett. 2020 Jul 9;11(8):1605-1610. doi: 10.1021/acsmedchemlett.0c00269. eCollection 2020 Aug 13.

Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story.肌苷酸脱氢酶抑制剂的抗肿瘤潜力：一个长达百年的故事

Cancers (Basel). 2019 Sep 11;11(9):1346. doi: 10.3390/cancers11091346.

Inosine-5'-monophosphate dehydrogenase is a rate-determining factor for p53-dependent growth regulation.肌苷-5'-单磷酸脱氢酶是p53依赖性生长调节的一个速率决定因素。

Mol Biol Cell. 1998 Jan;9(1):15-28. doi: 10.1091/mbc.9.1.15.

Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent.新型抗病毒药物2-β-D-呋喃核糖基硒唑-4-甲酰胺的广谱抗病毒活性

Antimicrob Agents Chemother. 1983 Sep;24(3):353-61. doi: 10.1128/AAC.24.3.353.

Tiazofurin: a new antitumor agent.

Invest New Drugs. 1984;2(1):79-84. doi: 10.1007/BF00173791.

Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses.利巴韦林与C-核苷类似物噻唑呋林和硒唑呋林对披膜病毒、布尼亚病毒和沙粒病毒的协同抗病毒作用。

Antimicrob Agents Chemother. 1984 Oct;26(4):476-80. doi: 10.1128/AAC.26.4.476.

Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.髓系前体细胞成熟过程中的嘌呤代谢。对HL-60细胞系的研究。

J Clin Invest. 1983 Dec;72(6):1889-900. doi: 10.1172/JCI111152.

Phase I and pharmacokinetic study of tiazofurin (TCAR, NSC 286193) administered by continuous infusion.

Invest New Drugs. 1985;3(4):349-55. doi: 10.1007/BF00170757.

Phase I and pharmacokinetic study of tiazofurin (NSC 286193) administered by 5-day continuous infusion.

Cancer Chemother Pharmacol. 1986;16(2):160-4. doi: 10.1007/BF00256168.

Modulation of nicotinamide adenine dinucleotide and poly(adenosine diphosphoribose) metabolism by the synthetic "C" nucleoside analogs, tiazofurin and selenazofurin. A new strategy for cancer chemotherapy.合成的“C”核苷类似物替拉扎明和硒代替拉扎明对烟酰胺腺嘌呤二核苷酸和聚（腺苷二磷酸核糖）代谢的调节作用。一种癌症化疗的新策略。

J Clin Invest. 1985 Feb;75(2):702-9. doi: 10.1172/JCI111750.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验